Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin by unknown
Inhibition of Desmin Expression Blocks Myoblast Fusion and 
Interferes with the Myogenic Regulators MyoD and Myogenin 
Hui Li, Suresh K. Choudhary, Derek J. Milner, Mohammad I. Munir, Ilmar R. Kuisk, 
and Yassemi Capetanaki 
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030 
Abstract.  The muscle-specific intermediate filament 
protein,  desmin,  is one of the earliest myogenic 
markers whose functional role during myogenic com- 
mitment and differentiation is unknown.  Sequence 
comparison of the presently isolated and fully char- 
acterized mouse desmin cDNA clones revealed a 
single domain of polypeptide similarity between des- 
min and the basic and helix-loop-helix region of 
members of the myoD family myogenic regulators. 
This further substantiated the need to search for the 
function of desmin.  Constructs designed to express 
anti-sense desmin RNA were used to obtain stably 
transfected C2C12 myoblast cell lines.  Several lines 
were obtained where expression of the anti-sense des- 
min RNA inhibited the expression of desmin RNA and 
protein down to basal levels. As a consequence, the 
differentiation of these myoblasts was blocked; com- 
plete inhibition of myoblast fusion and myotube forma- 
tion was observed. Rescue of the normal phenotype 
was achieved either by spontaneous revertants,  or by 
overexpression of the desmin sense RNA in the defec- 
tive cell lines.  In several of the cell lines obtained, in- 
hibition of desmin expression was followed by dif- 
ferential inhibition of the myogenic regulators myoD 
and/or myogenin, depending on the stage and extent of 
desmin inhibition  in these cells.  These data suggested 
that myogenesis is modulated by at least more than 
one pathway and desmin,  which so far was believed to 
be merely an architectural protein,  seems to play a 
key role in this process. 
D 
SblIN is  the muscle-specific  member of the inter- 
mediate  filament  (IF) 1 protein  multigene  family 
(Lazarides  and Hubbard, 1976). It is encoded by a 
single  gene (Capetanaki  et al.,  1984a;  Quax et al.,  1985; 
Herrman et al.,  1989; Li et al.,  1989; Li and Capetanaki, 
1993) which is expressed in all muscle types (for review see 
Lazarides,  1980;  Holtzer et al.,  1982;  Lazarides  et al., 
1982; Osborn et al., 1982; Lazarides and Capetanaki,  1986; 
Franke,  1987; Steinert and Roop, 1988). During early devel- 
opment desmin seems to be one of the earliest myogenic 
markers (Bennet  et al.,  1979; Gard and Lazarides,  1980; 
Kaufman and Foster,  1988; Hemnan et al.,  1989; Schaart 
et al., 1989; Choi et al., 1990). It first appears at 8.25 d post- 
coitus (dpc) in the neuroectoderm where it is transiently  ex- 
pressed together with vimentin and keratin.  Then it appears 
in the heart rudiment  at 8.5 dpc where no other muscle- 
specific gene product has yet been found and at 9.0 dpc it ap- 
pears in the myotome (Fiirst  et al.,  1989;  Schaart  et al., 
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1989). Desmin seems to be expressed at low levels in satel- 
lite  cells  (Allen  et  al.,  1991) and  replicating  myoblasts 
(Dlugosz et al., 1984; Hill et al., 1986; Kaufman and Foster, 
1988) which express high levels of the growth-regulated  IF 
protein vimentin.  Myogenesis  in vitro is accompanied by 
down-regulation  of vimentin and accumulation  of desmin 
(Bennett et al., 1979; Gard and Lazarides,  1980; Holtzer et 
al., 1982; Capetanaki  et al., 1984a,b; Fischman and Danto, 
1985;  Olson and Capetanaki,  1989).  We have previously 
shown  that  C2  myoblasts  transfected  with  oncogenic  ras 
genes  express  higher  vimentin  levels  and  fail  to  down- 
regulate vimentin  and up-regulate  desmin mRNAs (Olson 
and Capetanaki,  1989). Although these cells do not differen- 
tiate, they do express low levels of desmin suggesting that the 
regulation  of the initial expression of desmin is independent 
of terminal  differentiation. 
Because of the lack of any functional  studies,  we do not 
know the role of desmin in myoblasts, early in development 
or in terminally  differentiated  muscle.  The biological  func- 
tion of IF in general remains  elusive (for review see Traub, 
1985; Klymkowsky et al.,  1989). It was initially  suggested 
that in terminally differentiated myotubes, a potential role for 
desmin is  to  form a  transcytoplasmic integrating  matrix, 
linking  individual  myofibers laterally at their Z-disks and 
to the sarcolemma or longitudinally  connecting  successive 
Z-bands in elongating  myofibrils  (Granger and Lazarides, 
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1982; Price and Sanger,  1983; Lazarides  and Capetanaki, 
1986). However, recent in vitro data have shown that disrup- 
tion of desmin/vimentin  filaments does not interfere with the 
assembly, lateral alignment,  and maintenance  of the striated 
contracting  myofibrils (Schultheiss  et al.,  1991) suggesting 
that, at least in vitro, intact IFs are dispensable for these late 
processes of myogenesis. Additional data, accumulating  the 
last few years have allowed speculation  for alternative  func- 
tions for these molecules.  Vimentin and desmin seem to in- 
tercounect the nucleus to the plasma membrane (Woodcock, 
1980; Granger and Lazarides,  1982; Fey et al., 1984; Gold- 
man et al., 1985; Georgatos and Blobel, 1987a,b; Georgatos 
et al.,  1987). This could be achieved through  lamin B and 
ankyrin,  respectively  (Georgatos and Blobel, 1987a,b).  In 
addition to lamin B these molecules also show high affinity 
for other nuclear constituents,  like DNA and RNA (Traub, 
1985; Cress and Kurath,  1988; Sboeman et al., 1988). Fur- 
thermore,  it  was  recently  demonstrated  that  larnin  B 
specifically binds to nuclear matrix-associated  DNA regions 
(MARS) (Lud6rus et al., 1992). MARS are A-T-rich regions 
located in close vicinity to regulatory sequences or tran- 
scription unit boundaries (Mirkovitch  et al.,  1984; Gasser 
and Laemmli,  1986a,b; Jarman and Higgs,  1988; Phi-Van 
and  Str~itling, 1988) which by binding  to  nuclear matrix 
seem to activate gene expression (Stief et al., 1989; Phi Van 
et al.,  1990;  Grosveld et al.,  1987).  Considering  all  the 
above observations it could be envisioned  that desrnin and 
vimentin as well as other IF proteins could participate  in sig- 
nal transduction  and transport processes between the cell 
surface  and  the  nucleus  and  possibly  modulate  nuclear 
events. Indeed, it has been shown that mouse vimentin shares 
domains of significant similarity  (Capetanaki  et al., 1989b) 
with the DNA-binding domain and leucine zipper region of 
the transcription  regulators fos, jun (Bohmann et al., 1987; 
Ranscher  et al.,  1988;  Sassone-Corsi et al.,  1988),  and 
CREB, the cAMP-responsive  DNA binding protein (Gonza- 
lez et al.,  1989; Hoeffler et al.,  1988). The significance of 
such similarities,  if any, is completely unknown. In addition, 
over expression of vimentin has been linked to inhibition of 
differentiation  of eye lens cells in transgenic  mice (Capeta- 
naki et al., 1989a) and in C2 ceils in vitro (Olson and Cap- 
etanaki,  1989). 
All the above observations justified the need to search for 
the function of desmin during the initial and terminal  stages 
of myogenic differentiation.  We have isolated mouse desmin 
cDNAs and determined their complete primary amino acid 
structure.  Computer sequence homology search has revealed 
significant  homology between desmin  and  the basic and 
helix-loop-helix  (I-ILH) region of members of the MyoD 
family which include MyoD (Davis et al., 1987), myogenin 
(Edmondson and Olson, 1989; Wright et al., 1989), MRF4 
(Braun et al.,  1990;  Miner and Wold,  1990;  Rhodes and 
Konieczny, 1989), and Myf5 (Braun et al., 1989), All these 
myogenic  regulators  can  convert fibroblasts  to myoblasts 
through a mechanism requiring  a basic region and a domain 
with homology to the myc family postulated to adopt a HLH 
conformation (Murre et al.,  1989; for review see Emerson, 
1990;  Olson,  1990; Weintraub  et al.,  1991). All members 
of the myoD family are sequence-specific  DNA-binding pro- 
teins requiring  the basic and HLH region to bind to a con- 
sensus sequence CANNTG, known as an E box, and trigger 
muscle-specific  gene  transcription  (Braun  et  al.,  1990; 
Brennan et al., 1991; Davis et al., 1990). To investigate fur- 
ther  the biological  significance  of these homologies and 
study the role of desmin during  myogenesis,  we have in- 
hibited its expression and demonstrated that this blocked the 
myogenic differentiation program by inhibiting myoblast fu- 
sion and interfering  with the normal expression  pattern of 
myoD and/or myogenin. 
Materials and Methods 
Isolation of  Mouse Desmin cDNA 
The mouse desmin cDNAs were isolated from a mouse myogenic BC3H-1 
lambda-gtl0 eDNA  library (I.alPolla et al.,  1984),  provided  by Dr.  N. 
Davidson (California Institute of Technology, Pasadena, CA), by screening 
with a chicken desmin eDNA probe (Capetanaki et al.,  1984a) using con- 
ventional methods as previously  described (Capetanaki et al.,  1983). 
Nucleotide Sequencing and Analysis of 
Protein Structure 
Restriction fragments of the mouse desmin eDNA MDI02 were subcloned 
in M13 and part of the nucleotide sequencing was performed by the dideoxy 
method (Sanger et al., 1980). In addition, the MD102 insert was subcloned 
in bluescript and deletion clones were similarly sequenced.  Gaps were se- 
quenced using synthetic  desmin oligonucleotides  as primers.  The amino 
acid  sequence  was  deduced from  the  nucleotide  sequence  by  computer  using 
the Eugene program.  Sequence comparisons were performed using the 
Lawrence program (Lawrence and Goldman, 1988). 
RNA Isolation and Analysis 
C2C32 myoblasts  were  maintained and differentiated  as  previously  de- 
scribed (Olson and Capetanaki, 1989). RNAs from different stages during 
myogenesis  were isolated  by a  single step method using acid guanidin- 
ium thiocyanate-phenol  chloroform extraction (Chomczynski and Sacchi, 
1987).  RNA blot analysis  was performed as described previously (Cape- 
tanaki et al.,  1983) and the quantitative levels were determined by den- 
sitometry and normalized for the loading differences,  probe length, and 
specific activity. 
Cultures and Transfections 
The mouse skeletal muscle cell line C2C12 (Blan et al.,  1983) was grown 
in DME containing 20% FCS as previously described (Olson et al., 1986; 
Olson and Capetanaki, 1989). To initiate differentiation,  cultures at 80% 
conttuency  were transferred to DME containing 10% HS (or 2% FCS). 
Cultures of C2CI2 cells in 100 mM culture dishes containing ,~0.5  x  106 
cells were transfected by calcium phosphate precipitation (Oraham and Van 
der Ed, 1973) with the pMAM~o +  desmin constructs bearing the desmin 
eDNA in anti-sense and sense orientation, as shown in Fig. 4. The desmin 
in this construct was under transcriptional control of the mouse mammary 
tumor virus long terminal repeat (MMTV-LTR) aimed to confer glucocorti- 
cold  inducibility  to  the  eDNA. All inserts  in  this  construct  are  introduced 
in  the  SalI  side  of  the  polyllnker  of  pMAMneo vector  obtained  from Clon- 
tech  (Palo  Alto,  CA), which also  carries  the  neo gcne for  0418 selection. 
At 32 to 40 h after  transfecfion,  cells  were transferred  to three  100-ram 
dishes,  and 60 h after  transfection,  400 #g/ml 0418 was added to  the  cul- 
tures  of growth medium. Individual resistant colonies  were isolated 14 d 
later and passnged into stable cell fines. Cloual cell lines were exposed to 
~500 nM dexametlmsone and were tested fm-ther. Rescue of the defective 
phenotype was achieved by the use of constructs expressing high levels of 
sense desmin from the very strong cytomegalovirus  (CMV) enhancer/pro- 
moter. In this case the desmin cDNA was inserted into the pRc/CMV vec- 
tor, a modification  of pCMV~ (MacC-regor and Caskey,  1989), obtained 
from Invitrogen (San Diego,  CA) by directional cloning into the Hind- 
III/XbaI site of the polylinker.  20 #g of this vector were transfected into 
the fusion-suppressed  antisense cell lines by calcium phosphate precipita- 
tion, followed after 15 h by glycerol  shock, and the next day cells were 
switched to differentiation  promoting media and analyzed after 4 d. 
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eDNA synthesis of the desmin anti-sense RNA was performed with 10 #g 
total RNA using oligo(dT) as a primer. Part of the 3' half of the eDNA was 
amplified  by PCR using ~  DNA polymerase as previously  described 
(Salki et al., 1985) to detect the expression levels of the anti-sense desmin 
RNA. Denaturation, annealing, and extension were performed for 1 rain 
at 90°C, 2 rain at 60°C, and 3 rain at 72°C, respectively, in 40 cycles. PCR 
products were visualized by ethidium bromide staining. 
Immunofluorescence and Western Blot Analysis 
Immunofluorescence  microscopy was performed using standard techniques. 
In the case of staining for desmin 033 antibody [Danto and Fishman, 1984] 
or D-8281  antibody; Sigma  Chemical Co.,  St.  Louis, MO) and myosin 
(MF20 antibody) (Bader et al., 1982), cells were fixed in ethanol at -20°(2 
for 10 rain and the antibody incubations  were performed at 37°(2 for 30 rain. 
For detection of MyoD and myogenin, the antibodies used were obtained 
from Dr. Weintraub's (Tapscott et al.,  1988) and Dr. Wrights laboratories 
(Wright et al., 1991), respectively, and were incubated at room temperature 
for 1 h with cells fixed in 2% paraformaldehyde  for 10 rain and permeabi- 
lized with 0.15% Triton X-100 for 10 rain. Western blot analysis was per- 
formed with the Sigma desmin antibodies as previously  described (Cape- 
tanaki et ai.,  1989b). 
Results 
Isolation and Characterization of  Mouse 
Desmin cDNAs 
To isolate the mouse desmin cDNA, we screened a lambda- 
gfl0  eDNA  library  from  the  mouse  myogenic cell  line 
BC3H-1,  using the available  chicken desmin-specific probe 
(Capetanaki et al.,  1984a).  Several clones were obtained. 
The longest one, pMDI0-2,  1,497 bp, was subcloned into 
M13 and bluescript vectors and further characterized. 
Genomic DNA  blot analysis performed using pMD10z 
insert suggested that the desmin gene occurs once in the 
haploid mouse genome (data not shown). 
The nucleotide sequence of the entire insert from the iso- 
lated desmin eDNA clone, pMD102, was established by se- 
quence analysis of  both strands• The obtained sequence (Fig. 
1) comprises 1,497 bp which includes 83 bp of 5' untrans- 
lated region, 1,407 bp of coding sequence and only 7 bp of 
3' untranslated region. The 1,407-bp coding region of this 
eDNA revealed the total primary structure of mouse desmin 
comprising 469 amino acids•  Most of the 3' noncoding re- 
gion is missing. 
Analysis of the obtained mouse desmin protein sequence 
led to the assignment of the three structural domains estab- 
lished for all IF subunits studied to date (Geisler and Weber, 
1982).  These include a non-o~-helicai arginine rich NH2-ter- 
minal head piece of 85 residues, a central rod-like o~-helicai 
domain of 330 residues consisting of three a-helices sepa- 
rated by two short non-a-helical spacers and a non-c~-helical 
COOH-terminal tail piece of 45 residues (Fig.  1).  The as- 
signed a-helices contain the characteristic seven-residue re- 
peat pattern with hydrophobic amino acids at the first (a) and 
fourth (d) position of the heptad (a to g), involved in forma- 
tion of IF coiled-coil quaternary structure. 
Amino acid sequence comparison between mouse des- 
rain and the available sequences from other species revealed 
very high identity to hamster (98.7%),  human (95.1%),  and 
chicken (80.2%) (data not shown). Comparison of desmin 
with the other mouse IF proteins showed the highest homol- 
ogy to vimentin (61%). 
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Figure 1. Nucleotide sequence and the predicted complete amino 
acid sequence of mouse desmin from BC3H-1 cells. Initiation and 
termination codons are underlined. Mouse vimentin (Capetanaki 
et al., 1990) is included for comparison. The non-~-helical head 
(NH~-terminus) and tail (COOH-terminus) domains and the a-helP 
cal rod middle domain are indicated. Hydrophobic  residues in posi- 
tions a and d of the heptads are indicated by dots below vimentin 
sequence. This sequence data is available from EMBL/GenBank/ 
DDBJ under accession number L22550. 
Adjacent Regions of  Desmin Show Similarity 
to the Basic and HLH Region of  Members of  the 
MyoD Family 
We have recently shown that the growth-regulated IF pro- 
tein vimentin shares domains of similarity with the DNA- 
binding/leucine zipper motif of the growth regulators fos, 
jun, and CREB (Capetanaki et al., 1990)• We wanted to de- 
termine if a similar relationship exists between the muscle- 
specific IF protein desmin and the known myogenic regula- 
tory proteins. A computer sequence search revealed a single 
domain of homology (Fig. 2). Interestingly, this domain is 
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Figure 2. Similarity between desmin and myogenic members of the 
HLH motif containing family. Sequences were aligned to maximize 
similarity of desmin (DESM) to the shown consensus  1 sequence 
for the HLH region of all known members adapted from Murre et 
al., 1989. Consensus 2 is deduced by comparison of  desmin, myoD 
(Davis et al.,  1990), myogenin (myoG) (Edmondson and Olson, 
1989), and El2 (Murre et al., 1989). The ff symbol indicates hydro- 
phobic residues.  The capitals  in consensus 2 indicate identity to 
consensus 1. Dots represent gaps in sequence introduced to allow 
the alignment. Dots above the vimentin sequence indicate the hy- 
drophobic residues in positions a and d of the heptads of desmin 
and vimentin. Dashed lines above desmin show the amino acids of 
vimentin (VIM) identical to desmin. The end of helix Ia and begin- 
ning of helix Ib of vimentin  and desmin are indicated by arrows 
above the sequences. The basic domain and the helix I and helix 
II of the HLH family are underlined below the sequences. Identity 
to desmin amino acids is indicated by a vertical line above the corre- 
sponding amino acids. Stars  (*) show conserved amino acids. 
the  initially  reported  myc-like  DNA-binding  domain  of 
myoD found to be sufficient for activation of the muscle dif- 
ferentiation program (Tapscott et al.,  1988).  It includes the 
proposed HLH motif present in all known members of the 
myoD family, necessary for obligatory heterodimer forma- 
tion with the ubiquitous HLH proteins El2 and E47 (Murre 
et al.,  1989),  and overlaps the basic region responsible for 
DNA binding (Davis et al.,  1990). The similarity to desmin 
covers the end of desmin helix Ia, the linker, and the begin- 
ning of helix Ib. Among all the known members of the HLH 
family, myoD, myogenin, and El2 show the highest similar- 
ity to desmin.  Desmin closely follows the consensus pro- 
posed (Murre et al.,  1989) for all the above HLH proteins 
(Fig. 2, consensus 1 ). When the group is restricted to des- 
min, myoD, myogenin, and El2, a more extensive consensus 
is revealed (Fig. 2, consensus 2). The observed similarities 
apply to other members of the IF family including vimentin 
which shows highest similarity at the basic and helix I region 
and the least in helix II. Lamin C, however, follows the con- 
sensus mainly in helix II and not in the other two domains 
(Murre et al.,  1989). Further comparisons of mouse desmin 
also  revealed domains of similarity with the transcription 
factors, fos, jun, and CREB, as predicted due to its high ho- 
mology with vimentin (Capetanaki et ai.,  1990).  An inter- 
esting aspect of all the above similarities is that they all are 
localized at the same overlapping or adjacent regions of des- 
min, that is the end of helix Ia and the beginning of the helix 
Ib (data not shown). 
Expression of  Desmin in Comparison to MyoD and 
Myogenin During Myogenesis In Vitro 
To investigate the expression of desmin in  relation to the 
Figure 3. Comparison of the expression pattern of desmin relative 
to  myoD, myogenin,  and  vimentin  RNA  during  growth  and 
differentiation of C2C12 cells.  10  #g  total  RNA  from different 
times after plating (0 h, 12 h to 48 h) in growth medium (DME with 
20% FCS; GM) or different times alter transferring to differentia- 
tion/fusion  promoting  medium  (DME  with  10%  HS;DM/FM) 
(Day 0, (DO), DO +  4-18 h, D1-D10) of the myogenic C2C~2 cells 
were fractionated on 1.3 % agarose/formaldehyde gels, transferred 
to nitrocellulose, and hybridized with the mouse desmin, vimentin, 
myoD (Davis et al.,  1990), myogenin (Edmondson  and  Olson, 
1989), and 28S rRNA 32p-labeled cDNA inserts.  The 28S ribo- 
somal blot was used as internal  control for RNA concentration. 
In lane DO +  8 h, only 7.5/zg RNA was used. On day 0 (68 h after 
plating), when the high serum was withdrawn, cultures had reached 
80% contluency. X-ray exposure for desmin, vimentin, and myoge- 
nin was 18 h; for myoD 3.5 d and 28S 20 min. 
transcription regulators, myoD, and myogenin, we examined 
the accumulation of their mRNA at very early stages and 
throughout myogenesis of C2CI2 cells (Fig.  3).  Analysis of 
myoblasts growing in high serum concentrations any time af- 
ter plating exhibit easily detectable levels of desmin mRNA, 
significantly lower levels of myoD mRNA (about 20% of that 
of desmin), and no detectable myogenin mRNA. There is no 
significant increase of desmin and myoD RNA by 48 h after 
plating.  By 68  h  (DO in  Fig.  3),  however,  an increase of 
around  fivefold  is  observed  in  the  abundance  of desmin 
mRNA and threefold of myoD mRNA. It is not until 8 h after 
serum is withdrawn that myogenin mRNA is first detected, 
and then exhibits a fourfold induction by 18 h and a 24-fold 
increase by 24  h  after switching  to differentiation media. 
This data is consistent with previously reported observations 
(Edmondson and Olson, 1989; Wright et al., 1989). Interest- 
ingly,  a  36-38%  decrease  in  the  abundance  of myogenin 
mRNA is observed by day 4, followed by an increase which, 
by day  10,  rises 23-fold above the basal level. After with- 
clrawal of the high serum from the media, desmin mRNA 
shows an 18% increase in 4 h, while myoD mRNA does not 
seem to change before 12 h. By 24 h, however, myoD mRNA 
reaches  its  maximum  level  (about  eight  times  the  basal 
value), then drops to three times the basal level by the third 
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under the dexamethasone MMTV inducible promoter. The entire 
cDNAs (102) or the truncated form  123 (nt 650-1,490) were in- 
serted at the SalI site of the multiple cloning site of pMAM~o by 
blunt-ended ligations. The E. coli  neo gene for selection is incorpo- 
rated in the same vector. Small bars above  the construct 102 indi- 
cate the position of PCR primers used in Fig. 6. 
day and then in 3 d, increases again sixfold above the basal 
level and  shows  only slight decrease by day  10.  Desmin 
mRNA,  on the  other hand,  increases  linearly to  day  10 
achieving a level 27 times basal concentration. Notably, an 
abrupt decrease by day 2 of both myoD and myogenin is ob- 
served when the accumulation of these RNAs is quantitated 
densitometrically and normalized by the 28S ribosomal sig- 
nal (data not shown). The pattern of  vimentin mRNA expres- 
sion  during  C2C~2 cell  differentiation is  also  included  in 
Fig. 3. It has already been shown that, contrary to desmin, 
the abundance of  vimentin mRNA decreases during myogen- 
esis (Capetanaki et al.,  1983,  1984a,b; Olson and Capeta- 
naki,  1989). By 68 h after plating, vimentin mRNA abun- 
dance decreases by 66%.  12 h after serum withdrawal from 
the media, vimentin mRNA decreases to 24 % the starting 
level and interestingly, after six hours,  shows a  sharp in- 
crease (25 % of  basal level) and then decreases again. By day 
10, vimentin mRNA decreases to only 9 % of the basal level. 
Inhibition of  Desmin Expression by Anti-sense RNA 
In order to inhibit the expression of  desmin during myogene- 
sis in vitro, the constructs shown in Fig. 4  were prepared. 
The entire mouse desmin eDNA (10:) or a truncated form of 
it (123) missing the 1/3 5' end of the molecule were inserted 
in  both  sense  and  anti-sense  orientation in  the pMEM~o 
vector where the strong Rouse sarcoma virus-LTR (RSV- 
LTR)  enhancer is  linked  to the dexamethasone inducible 
MMTV-LTR promoter for control of high level expression. 
In the present experiments, however, this promoter was leak- 
ing significantly so that constitutive expression was inevita- 
ble (see below). C2Ct~ cells were transfected with the above 
constructs and colonies resistant to G418 were isolated and 
screened by Southern blot analysis. One to five copies of the 
desmin  constructs  were incorporated in  the  stably  trans- 
fected cell lines obtained (data not shown). 
Several of these colonies were grown for 24 or 48 h at sub- 
confluent densities in growth medium (DME with 20% FCS) 
in the presence of 0.5/~M dexamethasone.  As mentioned 
above, under these conditions, C2 myoblasts proliferate and 
express low levels of desmin and myoD (Fig. 3) but no myo- 
genin or other myogenic regulatory proteins.  When these 
cell lines reached 80% confluency, they were transferred to 
differentiation-promoting medium (DME with 2 % FCS or 
10%  HS, also containing 0.5/~M dexamethasone). Normal 
C2  myoblasts  under  such  conditions  start  fusing  to  mul- 
tinucleate  myotubes  and  the  onset  of  differentiation  is 
marked by induction of myogenin mRNA and increased ac- 
cumulation of desmin mRNA  and the rest of the muscle- 
specific gene products. 
Figure 5. Inhibition of desmin expression by anti-sense RNA. (A) 
Northern blot analysis of  total RNA from cell lines bearing the anti- 
sense (-) and sense (+)  102 and 123 constructs from Fig. 4, and 
cultured in growth medium (G) or, after achieving 80% conflueney, 
switched to differentiation promoting medium (D) for 48 h. The 
blot with a 28S ribosomal probe used as an internal control for 
RNA concentration is shown in Fig. 8. (B) Western blot analysis 
with desmin antibodies was performed using total protein isolated 
from the above cell lines at the corresponding stages. 
To determine the effect of the anti-sense RNA on the level 
of desmin expression in the transfected cell lines, we exam- 
ined both RNA and protein. Total RNA isolated from cul- 
tures  grown for 48  h  in growth medium or switched and 
maintained  for 48 h  in  differentiation-promoting medium 
was  analyzed by Northern blots using  the mouse desmin 
eDNA insert MD10:. Fig. 5 A shows examples out of several 
anti-sense cell lines studied where a dramatic or moderate 
suppression of desmin mRNA accumulation had occurred. 
Densitomentry of the obtained blots and normalization for 
RNA content against 28S ribosomal RNA (not shown) al- 
lowed approximate quantitation of the observed inhibition. 
In cell line 105.1.05 considerable desmin mRNA inhibition 
was displayed both in cultures maintained 48 h  in growth 
(>99 %  ) and differentiation (~ 85 %)-promoting medium. On 
the other hand, clone 10:.1.02  exhibited maximum desmin 
mRNA inhibition in cultures maintained for 48 h in differen- 
tiation-promoting medium (~93 %), whereas during growth 
no detectable inhibition was observed. Clone 123.1.04 pro- 
duced an inhibition pattern similar to that of 102.1.05 but to 
a lesser extent; under growth and differentiation conditions 
inhibition was ~22 and *62%, respectively. No change was 
observed in those cell lines transfected with constructs of 
desmin in sense orientation (105.7.14). 
When the desmin anti-sense RNA effect was examined at 
the protein level by Western blot analysis (Fig. 5 B), in most 
cell lines desmin protein was suppressed proportionally to 
the suppression of desmin mRNA. Clone 10:.1.05 showed a 
60% inhibition of desmin in growth and 85% inhibition un- 
der differentiation-promoting conditions. Similarly, in clone 
123.1.04 there was a 27 and 70% inhibition of desmin under 
growth  and  differentiation conditions,  respectively. There 
were cases however, like clone 105.1.02 where protein inhi- 
bition under growth conditions for instance, reached up to 
50 % of the normal level while no RNA inhibition was ob- 
served. Different mechanisms of anti-sense action could ex- 
plain such observations (see Discussion). Under differentia- 
tion conditions the same clone demonstrated desmin inhibition 
at both protein (70%) and RNA level (93%). Similar results 
were obtained regardless of the presence or absence of dexa- 
methasone, which initially suggested constitutive expression 
Li et al. Desmin, a Potential Modulator of Myogenesis  831 Figure 6.  Detection of desmin anti-sense RNA in cells with in- 
hibited  desmin  expression.  Total RNA  isolated  from  cell  line 
123.1.04 (described in Figs. 5 and 6) after 24 h (lanes 2 and 3) and 
48 h (lane 4) in growth medium (GM) or 12 h (lane 5), 24 h (lane 
6), 36 h (lane 7), and 48 h 0ane 8) after switching  to differentiation 
promoting medium (DM) was analyzed by reverse transcription- 
PCR using oligo (dT) and the primer shown in Fig. 4. Several con- 
trois are included: RNA from normal C2C12 cells (lane 1 ) cultured 
for 48 h in GMand from cell line 102.7.14  bearing the desmin con- 
struct in sense orientation and cultured for 48 h in GM (lane 9) or 
48 h after switching  to DM (lane 10). In lane 2, cells were cultured 
in the absence of dexamethasone in contrast to all the other cases. 
Lane 11 contains buffer only and lane 12 contains control plasmid. 
The  expected  835-bp long  PCR  products  were  visualized by 
ethidium bromide staining. 
of the anti-sense RNA from the constructs used and that is 
indeed documented in Fig. 6, lane 2. 
Initial attempts to detect the desmin anti-sense RNA tran- 
scribed from the transfected constructs using RNA blot anal- 
ysis were not successful. Given the fact that sense-antisense 
RNA duplex formation and rapid degradation is one of the 
accepted mechanisms of  anti-sense action, the expected anti- 
sense RNA  surviving this process could be of low abun- 
dance. To detect low levels of desmin anti-sense RNA from 
different cell lines, total RNA from cultures maintained in 
growth or differentiation-promoting medium in the presence 
or absence of dexarnethasone was analyzed by reverse tran- 
scription followed by PCR (Fig. 6). Anti-sense RNA could 
be detected in only one (123.1.04) of the three transfected 
cell lines analyzed. Interestingly in those ceil lines where the 
most dramatic endogenous desmin inhibition was observed, 
such as  102.1.05 and 102.1.02, no anti-sense RNA could be 
detected even as early as 6 h after plating. Similar observa- 
tions of simultaneous reduction or disappearance of sense 
and anti-sense RNA have been reported in other systems 
(Sheehy et al., 1988; Smith et al., 1988; Van der Krol et al., 
1988; Hamilton et al., 1990). The expression of the desmin 
anti-sense mRNA in the 123.1.04 cell line was further ana- 
lyzed. As shown in lane 2 of Fig. 6 anti-sense RNA was ex- 
pressed in the absence of dexamethasone at levels close to 
those attained in the presence of dexamethasone (lane 3). 
This confirmed the leakiness of  the vectors and explained the 
above observations. The abundance of the anti-sense RNA 
did not change from 24 to 48 h in growth medium. However 
anti-sense RNA could not be detected during the initial 36 h 
after switching to differentiation-promoting medium but it 
reappeared at 48 h in differentiation medium at levels com- 
parable to those attained in cultures maintained in growth 
medium. 
Inhibition of  Desmin Expression  Blocks Myoblast 
Fusion and Myotube Formation 
Morphological analysis  of the desmin-defective cell lines 
demonstrated the failure of these myoblasts to fuse and form 
multinucleated myotubes.  Fig.  7,  bottom,  shows the mor- 
phology of one of the  analyzed cell lines,  102.1.02,  dis- 
playing inhibited desmin expression (Fig.  5),  after 4  d  in 
differentiation-promoting  medium. In growth medium, these 
cells were initially morphologically indistinguishable from 
the nontransfected normal C2C12 myoblasts, or transfectant 
102.7.14 with  the  desmin  construct  in  sense  orientation. 
When the cultures were transferred to differentiation-pro- 
moting medium, inhibition of  fusion was observed. Even 4 d 
after the switch to this medium, no particular change in the 
behavior of these inhibited myoblasts was observed (Fig. 7, 
bottom). 70% of the 31 (3418 resistant anti-sense cell lines 
analyzed demonstrated similar inhibition in myoblast fusion. 
In contrast, more than 90% of the 12 cell lines bearing des- 
rain constructs in the sense orientation (Fig. 7, middle) fused 
and differentiated as well as normal C2C12 cultures (Fig. 7, 
top). 
Rescue of the Normal Myogenic Phenotype 
To demonstrate that the inhibition of the myogenic differenti- 
ation observed above is indeed due to desmin inhibition and 
not a random defect of the isolated cell lines, rescue of the 
normal differentiation was achieved by two different ways. 
The first one was obtained due to spontaneous revertants 
when cells were cultured and passaged  in the absence of 
G418 selection (Fig. 8). Up to about 5% of the cells seemed 
to fuse again and the majority of them formed single myo- 
tubes of relatively short length (Fig. 8 b). This does not hap- 
pen when cells are cultured in the presence of G418 (Fig. 
8 a).  A very low percentage of these revertants form long 
myotubes, as shown in Fig.  8 b, and very rarely branched 
ones.  102.1.05 was the cell fine with the highest percent of 
revertants. The second way the normal phenotype was res- 
cued was  when the desmin-defected cell lines  were tran- 
siently transfected with the pRc/CMVdes construct which al- 
lows expression of  high levels of  desmin sense RNA from the 
strong CMV promoter described in methods (Figs. 8 c and 
9). Transient transfections of  the defected cell lines with this 
vector could rescue the myogenic  phenotype, at least in 20 % 
of the cell population, in 4  d  (Figs.  8 c, and 9, D  and E). 
Myoblast fusion and myotube formation looked very similar 
to that of normal C2Cj2 cells. In addition to the higher num- 
ber of fusing cells in this case (Fig. 8 c), another prominent 
difference with the spontaneous revertants (Fig. 8 b) was the 
higher frequency of long and branched myotubes formed. 
These differences obviously must be due to the high number 
of cells expressing adequate levels of desmin from the trans- 
fected pRe/CMVdes  vector.  Indeed,  immunofluorescence 
microscopy revealed that  in  contrast to the untransfected 
102.1.05 cells (Fig.  9 B), those transfected with pRc/CMVdes 
vector showed high levels of desmin expression (Figs. 9, C 
and D). It is of interest to note that when cells with high lev- 
els of desmin expression, such as the one shown in C of Fig. 
9,  were  surrounded by desmin  negative cells,  they often 
showed long extensions but did not fuse with neighboring 
cells, suggesting that fusion might take place only between 
desmin positive ceils. Staining of the transfected cells with 
myosin heavy chain (MHC) antibodies demonstrated that in 
these desmin revertants the normal myogenic phenotype is 
accompanied by normal endogenous MHC expression (Fig. 
The Journal of Cell Biology,  Volume  124,  1994  832 Figure 7. Inhibition  of desmin blocks fusion and myotube formation of the C2Ct2 myogenic cells. Normal C2Ct2 cells (top) and cell lines 
bearing the desmin construct in sense orientation (middle) are compared with one of the anti-sense cell line (102.1.02) with inhibited des- 
min expression (bottom) due to anti-sense RNA. Cells were cultured as described in Fig, 5 in growth medium and after achieving 80% 
confluency, cultures were transferred  to differentiation promoting medium for 4 d. Bars:  (Growth) 20/tin; (Differentiation)  10/~m. 
Li et al. Desmin, a Potential Modulator of Myogenesis  833 Figure 8. Rescue of the normal myogenic phenotype.  Phase micrographs of the fusion suppressed anti-sense cell line 102.1.05, grown with 
(a) or without (b) G418 selection or transfected with the pRc/CMVdes construct overexpressing sense desmin (c). (a) Cells were cultured 
in the presence of G418 for 48 h in GM, and then switched to DM for 4 d. (b) Cells were grown and passaged  for several days in the 
absence of G418 before the actual experiment.  After reaching 80% cortfluency, they were switched as above to DM for 4 d. (c) 102.1.05 
cells were grown in GM for 24 h before transfection with 20 ~g pRc/CMVdes vector DNA. Cells were switched the next day to DM and 
maintained for 4 more days. Bar, 5 ~m. 
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of desmin in normal C2C12 (,4) cells and 
the  fusion-suppressed  1021.05  anti-sense 
cell line before (B)  and  after (C and D) 
reversion (Rev) to the normal phenotype by 
pRc/CMVdes  transfection  and  culture  as 
described in Fig. 8. C shows an example of 
areas in the same culture dish as D with iso- 
lated cells expressing high desmin levels but 
unable  to  fuse  with  neighboring desmin 
negative cells. E  shows  MHC  staining of 
cells from the same culture as D. Bar,  10 
/~m. 
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observed inhibition of fusion in the different anti-sense cell 
lines obtained was indeed due to the inhibition of  desmin and 
not to a random defect of the isolated cell lines. 
Inhibition of  Desmin Interferes with the Expression  of 
Myogenic Regulators and Other Muscle-specific  Genes 
The data had demonstrated that suppression by anti-sense 
RNA of desmin, a protein with some similarity to the myo- 
genic regulators myoD and myogenin at the basic and HLH 
region caused inhibition of myoblast fusion and myotube for- 
mation. If desrnin participates in the modulation of myogen- 
esis, how does this correlate with the above two observa- 
tions? To determine whether the inhibition or reduction of 
desmin  has  influenced the  expression  of other  muscle- 
specific genes, RNA blots from one of the cell lines shown 
in Fig. 6, namely 102.1.02, were probed for myoD, myoge- 
nin, muscle creatine kinase (MCK), and actin. Interestingly, 
significant inhibition in the expression of both myoD and 
myogenin mRNA was evident in cultures maintained 48 h in 
differentiation medium as compared to normal C2C12 cells 
(Fig.  10 A). The extent of myoD and myogenin inhibition 
correlated,  in  most  cases  (70%  of cell  lines  analyzed), 
directly to the extent of desmin inhibition. In this particular 
case it is clearly shown that when desmin is inhibited in cul- 
tures maintained up to 48 h in differentiation medium (Fig. 
10 A, lane 4) both myoD and myogenin are inhibited. Ear- 
lier, however, when desmin has not yet been detectably de- 
creased, no obvious change in myoD has occurred (Fig.  10 
A, lane 3). Patterns of inhibition similar to those of myoge- 
nin mRNA were observed only for muscle-specific genes 
such as a-sarcomedc actin and MCK mRNA, but not for 
others like/~, -t-actins,  and vimentin (Fig. 10 A). This sug- 
gests  that  indeed,  the  effect is  specific  to  the  myogenic 
processes and not a random effect of the anti-sense RNA. 
Though the above described effect of desmin inhibition on 
the pattern of muscle gene expression is the most representa- 
tive  (70%  of cases  examined),  there  were  cell lines like 
102.1.05 where though the extent of myoD decrease directly 
reflected the level  of desmin inhibition, myogenin did not 
(Fig. 10 B, lane 4). In this cell line, where the inhibition of 
desmin mRNA was dramatic, very strong inhibition of  myoD 
mRNA was observed in both growth (94%) and differentia- 
tion (85%) conditions. Myogenin was not significantly in- 
hibited, however ("~13%) (Fig. 10 B, lane 4). In these cases 
a-sarcomeric actin and MCK expression looked very close 
to  normal  (data  not shown).  Fusion, however,  was com- 
pletely inhibited. On the other hand, there were cases, such 
as  clone  123.1.04,  where  myoD mRNA  was  mainly  in- 
hibited during growth (81%) (Fig. 10 B, lane 5), with little 
inhibition under differentiation conditions (22 %) (Fig. 10 B, 
lane  6),  when  myogenin displayed significant inhibition 
(90%) (Fig. 10 B, lane 6). In such cell lines, extensive inhi- 
bition of both MCK (67%) and t~-actin (73%) mRNA was 
observed (data not shown). It should be noted here that the 
observed inhibition of myoD or myogenin cannot be due to 
the desmin anti-sense RNA since the similarity between des- 
min and these proteins shown in Fig. 2, is restricted only 
to the protein level. In addition, the construct 123.1.04 (nt 
650-1,490)  which  shows  similar  results to  construct  102 
(Fig.  4) does not include this region (nt 348-498)  which 
Figure 10. Inhibition of desmin interferes with the expression of 
myogenic regulators myoD and myogenin  and their target genes. 
Northern blot analysis of total RNA from the cell line 102.1.02 (A) 
and  102.1.05 and  123.1.04 (B) with inhibited desmin expression 
described  in  Figs.  5,  6,  and  7  cultured in  growth (G)-  or 
differentiation-pmraoting  medium (D) for 48 h. Similar blots were 
hybridized, stripped, and rehybridized sequentially  with the differ- 
ent probes as indicated. 
shows the protein similarity between desmin and these pro- 
teins. 
Finally, we examined the pattern of myoD and myogenin 
protein expression in these cell lines by immunofluorescence 
microscopy. As shown in Fig.  11 the nuclear staining pat- 
terns obtained are in direct agreement with the MyoD and 
myogenin RNA data shown in Fig. 10. For instance, in cul- 
tures  maintained under  differentiation condition,  102.102 
cell line shows no nuclear staining for either myoD or myo- 
genin, while 102.1.05 and  123.1.04 show staining only for 
one of these factors, myogenin or myoD, respectively. Fur- 
thermore, it is demonstrated that the degree of inhibition ob- 
served at the RNA level of these factors reflects mainly the 
number of cells expressing rather than levels of expression 
in single cells. 
Discussion 
IS Desmin Necessary for Myogenesis to Take Place and 
What Could Be Its Role during This Process? 
Desmin is expressed both early and late in the myogenic pro- 
gram. It is one of the earliest myogenic markers both in vivo 
(Schaart et al., 1989) and in tissue culture, being expressed 
in replicating presumptive myoblasts (Dlugosz et al., 1984; 
Hill et ai.,  1986; Kaufman and Foster, 1988),  That the ap- 
pearance of desmin marks a very early event in myogenesis 
has been further supported by the fact that several nonmuscle 
cells, in the process of conversion into the myogenic lineage 
due to expression of exogenous myoD, start synthesizing 
desmin before the synthesis of any myofibrillar protein and 
before fusion (Choi et al., 1990). Similarly, during early de- 
velopment in mice, desmin has been shown to be one of the 
The Journal  of Cell Biology,  Volume 124, 1994  836 Figure 11. Immunofluorescence  microscopy of MyoD and myogenin  in normal C2C12 and different fusion-suppressed antisense cell lines. 
Cells cultured 2 d in growth (GM) and consequently switched for three more days in differentiation media (DM) were incubated with 
mouse myoD or myogenin antibodies. Bar, 10 gm. 
earliest expressed muscle-specific genes. The protein is ini- 
tially detected in the neuroectoderm at 8.25 dpc, transiently 
expressed with vimentin and keratin while no other muscle- 
specific protein has yet been identified. It then appears in the 
heart rudiment at 8.5 dpc and in myotome at 9.0 dpc, well 
before myoD and as soon as the MRF4 mRNA is detected 
(Sassoon et al., 1989).  Correlations with the appearance of 
Myf5 (Braun et al., 1990) and myogenin cannot be directly 
made since the time these proteins appear is unknown; their 
RNA is detected in the somites on 8.0 and 9.0 dpc, respec- 
tively. It would be interesting to determine what the role of 
desmin might be during these early events of  myogenic  deter- 
mination and differentiation. Is desmin necessary for myo- 
genesis to take place or for the maintenance of the myogenic 
phenotype? 
Our present data have suggested that desmin might indeed 
be necessary for normal myogenesis to take place. Inhibition 
of desmin expression interfered with the normal induction of 
muscle-specific gene products in C2C~2 cells and blocked 
myoblast fusion and myotube formation. These results sug- 
gested that the muscle-specific IF protein desmin, so far con- 
sidered merely a component of the supporting cell architec- 
ture,  might be  a  central molecule regulating myogenesis 
through direct or indirect modulation of myogenic regulators 
and myoblast fusion. In addition to vimentin (Capetanaki et 
al.,  1989)  and desmin (this article),  another intermediate 
filament protein, glial fibrillary acidic protein (GFAP)  has 
been linked to a differentiation-associated function (Wein- 
stein et al.,  1991). It is intriguing that all of these proteins 
are type HI IF, showing the highest similarity to each other 
in comparison to the rest of the members of the IF super- 
family. The present data cannot address possible direct in- 
volvement of desmin in myoblast fusion. This possibility, 
however, could be favored by the observation that ectopic ex- 
prcssion  of  desmin in  the  lenses  of  transgcnic  mice causes, 
among other  abnormalities,  partial  plasma membrane fusion 
(Krimpenfort et  al.,  1988; Dunia et  al.,  1990).  On the  other 
hand, from the  present  rescue studies  it  could be suggested 
that  possibly  only desmin positive  myoblasts can fuse  (Fig. 
9 C). However, this  is  not  proven from the  present  data,  al- 
though it  is  consistent  with recent  observations  on primary 
chick myoblasts  (Lin et al., 1994)  as well as in rayeD- 
converted  normal cells  (Choi  ct  al.,  1990) which do  not  fuse 
before  becoming desrnin  positive. 
In the present study the different  cell lines obtained 
showed differential  inhibition  of  myoD and myogenin in  re- 
sponse to the  inhibition  of  desmin. The extent  and stage  of 
rayeD inhibition  directly  correlated  with the extent  of  des- 
rain inhibition  and the stage of the C2Ct2 cells.  However 
this  was not  the  case for  myogenin. Only 60  %  of  these  lines 
showed substantial  inhibition  of  myogenin following  desmin 
inhibition.  It  is  not  yet  clear  how this  differential  effect  takes 
place. It could be explained,  however, by the already sug- 
gested  multiple  pathway process  for  myogenic differentiation 
in vivo (Sassoon  et al., 1989; Cusella-De-Angelis  et al., 
1992).  How  the absence  or decrease  of desmin  could 
influence the accumulation  of these myogenic  factors  is 
difficult  to  predict.  At  the  present  time  we  do  not  really  know 
if  this  effect  is  the  first  consequence of  desmin inhibition  or 
if  it  follows  after  myogenesis has been inhibited  by an  inde- 
pendent  mechanism. Furthermore, we  do  not  know if  the  ob- 
served  mRNA  decrease takes  place  at  the  transcriptional  or 
postranscriptional level. Sequence  comparison  revealed 
(Fig. 2) that  the region  of  dcsmin (116-207) which covers 
part  of  helix  la,  the  linker,  and  part  of  helix  Ib  has significant 
sequence similarity  to  members of  the  HLH  family,  particu- 
laxly  the  myogenic regulator  myoD, myogenin, and  the  KE2 
(immunoglobulin enhancer)-binding protein  El2 (Murre et 
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show similarity to the basic and leucine zipper domains of 
the transcription factors jun, fos, and CREB. It is interesting 
that two adjacent regions of desmin demonstrate similarity 
to the very important functional regions of members of two 
different transcription factor protein families acquiring ei- 
ther the HLH or the leucine zipper motifs. It should be fur- 
ther noted here that members of these families seem to func- 
tion  antagonistically,  possibly  by  using  these  important 
domains (Bengal et al., 1992; Li et al., 1992). Nuclear lain- 
ins, the nuclear counterpart members of the IF family, also 
show some similarity to the HLH family members but not 
to the same extent as does desmin with the myoD family 
(Murre et ai.,  1989).  The biological significance of these 
similarities is completely unknown. The effect of desmin in- 
hibition on the expression of MyoD and myogenin could al- 
low some speculations that have to be proven experimentally. 
One could assume that the above discussed similarities may 
reflect possible association and modulating interactions be- 
tween the homologous a-helical domains of these proteins 
at some stage during muscle differentiation, as we have pre- 
viously suggested for the observed corresponding similari- 
ties between the growth-regulated IF protein vimentin and 
the  growth  regulators  fos,  jun,  and  CREB  during  cell 
proliferation (Capetanaki et al., 1990). This can be a mecha- 
nism by which desmin filaments could be involved in signal 
transduction and transport of these myogenic factors to the 
nucleus or in the modulation of  muscle chromatin conforma- 
tion. Neither desmin nor vimentin has been found in the nu- 
cleus. However,  they both seem to interlink the nucleus to 
the plasma membrane and the possibility of penetrating the 
nucleus and interacting with nuclear constituents cannot be 
excluded; on the contrary, it is favored by the a/ready demon- 
strated interactions of desmin and/or vimentin with different 
nuclear constituents including lamin B,  RNA, DNA, and 
histones  (Traub,  1985;  Georgatos  and  Blobel,  1987a,b; 
Cress and Kurath,  1988;  Shoeman et al.,  1988).  As men- 
tioned above,  recent data have demonstrated that lamin B 
specifically binds to MARS, which when bound to nuclear 
matrix activate gene expression; however, the functional role 
of the lamin B binding to MARS is unknown. Considering 
the above data, one could envision that the connection of the 
cytoplasmic IF  with the  nuclear  lamins could  somehow 
influence nuclear events that might be modulated through 
lamin B-MARS binding. Recent data on mechanotransduc- 
tion across the cell surface and through the cytoskeleton, 
including the IF system (Wang et al.,  1993;  for review see 
Ingber,  1993),  complements all the above considerations. 
Alternatively, the desmin filaments could just facilitate the 
transport  of myoD and myogenin into the  nucleus or of 
myoD, myogenin and the other muscle-specific RNAs out in 
the cytoplasm. It has been recently reported that 3' untrans- 
lated regions (3TITRs) of muscle-specific genes seem to be 
responsible for the maintenance of the muscle-differentiated 
state (Rastinejad and Blau,  1993).  If desmin filaments as- 
sociate with muscle mRNAs as proposed for keratins and 
maternal Vgl mRNA in Xenopus oocytes (Pondel and King, 
1988;  for review see Klymkowsky et al.,  1989) their lack 
might inhibit myogenesis by blocking the function of the 
3'UTRs  of the muscle RNAs.  On  the  other hand,  given 
the  above  described  importance  of the  YUTR  region of 
some muscle-specific mRNAS on muscle differentiation one 
should seriously consider that the effects of the desmin anti- 
sense RNA on muscle differentiation might not be just due 
to the decrease of the desmin protein, but the decrease of its 
mRNA and thus its 3'UTRs. It should be pointed out that the 
obtained rescue of the normal phenotype here by the overex- 
pression of sense desmin RNA is probably not achieved by 
the exogenous RNA using the same mechanism since the 
construct used lacks the desmin 3TITR. It could be, however, 
due to the endogenous desmin mRNA and YUTR which was 
able to accumulate in such rescue experiments. 
Of interest is the correlation of the presently obtained ceil 
lines with the known fusion-defective  BC3H1 cell line. It has 
been shown that the fusion defect of these rayeD-negative, 
myogenin-positive cells can be reversed by expressing rayeD 
in these cells (Brennan et al., 1991). Desmin is expressed in 
this cell line but at lower levels which would correlate with 
the expression pattern in the  102.1.05 cell line.  The data 
from the BC3H1 study and that of the present study suggest: 
(a) MyoD by itself is not sufficient for normal myogenesis 
to take place. (b) Normal myogenin levels are required for 
normal  myogenesis and  muscle-specific  gene  expression 
consistent with the recent data on the disruption of the myo- 
genin  gene  by homologous recombination (Hasty et al., 
1993).  (c) Inhibition of desmin leads to negative regulation 
of myoD which is always linked to inhibition of fusion. (d) 
Inhibition of desmin is not necessarily followed by myogenin 
inhibition. (e) More than one pathway seem to be responsible 
for the control of myogenesis. 
Does desmin play different or additionai roles at the later 
stages of muscle differentiation? After fusion of myoblasts 
into multinucleated myotubes, desmin IF gradually rear- 
range from a radial and random distribution to form trans- 
verse bands surrounding the Z-disks and connecting neigh- 
boring myofibrils (Bennett et al., 1979; Gard and Lazarides, 
1980; Holtzer et al.,  1982;  Fuseler et ai.,  1983; Tokuyasu 
et al., 1984).  Thus it has been postulated that later in myo- 
genesis desmin might play a critical role in the lateral alig  n- 
ment  of the  myofibrils,  their  connection  to  each  other 
through their Z-disks, to other organelles, and the whole sys- 
tem to the sarcolemma (Lazarides, 1980;  Lazarides et al., 
1982).  Recent in vitro data, however, have shown that dis- 
ruption of desmin/vimentin filaments by expressing exoge- 
nous truncated desmin protein did not interfere with the 
assembly, lateral alignment, and the maintenance of the stri- 
ated contracting myofibrils (Schultbeiss et al.,  1991). This 
data indirectly suggest reconsideration of those older hy- 
potheses of desmin function and by extension, the function 
of IF proteins in general. Nevertheless, possible structural 
roles of at least keratins and neurofilaments in the organiza- 
tion and integrity of cells and tissues have been indirectly 
suggested from work in transgenic mice and genetic diseases 
(Coulombe et al.,  1991; Vassar et ai.,  1991; Cheng et al., 
1992; Chipev et al., 1992; Fuchs et al., 1992; Rothnagel et 
al., 1992; Xu et ai., 1993; for reviews see also Liem, 1993; 
Coulombe, 1993). 
Mechanism of the Inhibition of Desmin by 
Anti-sense RNA 
The mechanism of the presently reported inhibition of des- 
min by the anti-sense RNA is not completely clear. A major 
portion of the inhibition was obviously due to a decrease in 
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by which this decrease is effected can only be speculated 
based upon previous  observations  (Kim and Wold,  1985; 
Stout and Casky,  1990). The anti-sense RNA might interfere 
with RNA processing by hybridizing with the sense desmin 
RNA in the nucleus. The unprocessed or the double stranded 
RNA  would  then  be  poorly  or  not  transported  to  the 
cytoplasm and would be quickly degraded. This mechanism 
explains the presently obtained, intriguing mutual decrease 
or disappearance of both sense and anti-sense desmin RNA 
in those cases where the highest endogenous desmin RNA 
inhibition was observed. This is consistent with previously 
reported data in other systems including the plant hormone 
ethylene  (Hamilton et al.,  1990),  chalcone synthase  (Van- 
Beveren et al., 1983), and polygalacturonase (Sheehy et al., 
1988; Smith et al., 1988). In such cases it can be argued that 
the  possibility  of indirect nonspecific  contribution of the 
anti-sense RNA on the observed phenotype is considerably 
decreased  since this  RNA  is  quickly  degraded  and  never 
reaches  the  cytoplasm.  Finally,  an  additional  inhibition 
mechanism could directly involve inhibition of desmin trans- 
lation by the anti-sense RNA that reaches the cytoplasm. The 
extent to which the latter mechanism may be contributing  to 
the observed decrease of desmin in the obtained cell lines is 
unknown. In the case of the 102.1.02 cell line under growth 
conditions the desmin mRNA seems normal but the protein 
is reduced ~50%.  Obviously, just inhibition of translation 
seems to be the predominant mechanism of the antisense ac- 
tion here. 
Similar  anti-sense  RNA  approaches  have  been  used  to 
show that inhibition of another  IF protein, GFAP, blocked 
the formation of stable astrocytic processes (Weinstein et al., 
1991), suggesting that active involvement in the regulation of 
cell differentiation may be a function of all tissue-specific IF 
proteins. 
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